Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Industrial Holdings Limited (SIHL) is a prominent investment holding company and conglomerate based in Hong Kong, acting as the flagship listed subsidiary of the Shanghai Municipal Government's investment arm. The company maintains a diverse portfolio across infrastructure, real estate, and consumer products, with a strategic focus on the healthcare sector through its controlling interest in Shanghai Pharmaceuticals Holding Co., Ltd. As a major player in the Chinese life sciences industry, SIHL oversees an integrated pharmaceutical business that spans research and development, manufacturing, and a vast distribution network. Its healthcare operations cover a broad spectrum of therapeutic areas, including oncology, cardiovascular diseases, and immunology. The company is listed on the Hong Kong Stock Exchange and plays a critical role in the industrial modernization and international expansion of Shanghai-based enterprises.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Industrial Holdings.